Review



human malignant peripheral nerve sheath tumour cell line nms2  (BioResource International Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioResource International Inc human malignant peripheral nerve sheath tumour cell line nms2
    Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, <t>NMS2,</t> and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).
    Human Malignant Peripheral Nerve Sheath Tumour Cell Line Nms2, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+malignant+peripheral+nerve+sheath+tumour+cell+line+nms2/pmc05676745-150-2-18?v=BioResource+International+Inc
    Average 90 stars, based on 1 article reviews
    human malignant peripheral nerve sheath tumour cell line nms2 - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma"

    Article Title: Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma

    Journal: Scientific Reports

    doi: 10.1038/s41598-017-12660-5

    Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, NMS2, and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).
    Figure Legend Snippet: Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, NMS2, and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).

    Techniques Used: Biomarker Discovery, Expressing, Cell Culture, MANN-WHITNEY, Comparison



    Similar Products

    human malignant peripheral nerve sheath tumour cell line nms2  (BioResource International Inc)
    90
    BioResource International Inc human malignant peripheral nerve sheath tumour cell line nms2
    Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, <t>NMS2,</t> and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).
    Human Malignant Peripheral Nerve Sheath Tumour Cell Line Nms2, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+malignant+peripheral+nerve+sheath+tumour+cell+line+nms2/pmc05676745-150-2-18?v=BioResource+International+Inc
    Average 90 stars, based on 1 article reviews
    human malignant peripheral nerve sheath tumour cell line nms2 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, NMS2, and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).

    Journal: Scientific Reports

    Article Title: Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma

    doi: 10.1038/s41598-017-12660-5

    Figure Lengend Snippet: Differential diagnosis of synovial sarcoma from other soft tissue sarcomas by circulating/secreted miR-92b-3p . ( A , B ) The expression of miR-92b-3p and miR-150-3p in cells ( A ) and cell culture media ( B ) of SS (SYO-1, YaFuSS, HS-SY-II, and Yamato-SS) and the other STS cell lines (HT1080, NMS2, and UPS2023). The Mann-Whitney U test was used for comparison between groups. ( C ) Serum miR-92b-3p levels in SS patients and other STS patients ( p < 0.001). The Mann-Whitney U test was used for comparison between groups. ( D ) ROC curve analysis of miR-92b-3p discriminating SS patients from other STS patients. AUC was 0.88 (95% confidence interval = 0.72–1.0). ( E ) Serum miR-150-3p expression levels in SS patients and other STS patients. The Mann-Whitney U test was used for comparison between groups. ( F ) ROC curve analysis of miR-150-3p discriminating SS patients from other STS patients. AUC was 0.54 (95% confidence interval = 0.33–0.75).

    Article Snippet: A human malignant peripheral nerve sheath tumour cell line NMS2 was available from the cell bank of RIKEN BioResource Center (Ibaraki, Japan).

    Techniques: Biomarker Discovery, Expressing, Cell Culture, MANN-WHITNEY, Comparison